- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource
- Language
-
Englisch
- Bibliographic citation
-
Long-term low-dose transdermal buprenorphine therapy for chronic noncancer pain ; volume:1 ; number:3 ; year:2010 ; pages:120-121 ; extent:2
Scandinavian journal of pain ; 1, Heft 3 (2010), 120-121 (gesamt 2)
- Creator
-
Borchgrevink, Petter C.
- DOI
-
10.1016/j.sjpain.2010.05.034
- URN
-
urn:nbn:de:101:1-2024022313500527462137
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:44 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Borchgrevink, Petter C.
Other Objects (12)
Buprenorphine plasma and cerebrospinal fluid concentrations in osteoarthritis patients during low-dose transdermal patch dosing
Transdermal buprenorphine in cancer pain and palliative care
Cancer and non-cancer brain and eye effects of chronic low-dose ionizing radiation exposure
Rapid induction of transdermal buprenorphine to subcutaneous extended-release buprenorphine for the treatment of opioid use disorder
A 6-months, randomised, placebo-controlled evaluation of efficacy and tolerability of a low-dose 7-day buprenorphine transdermal patch in osteoarthritis patients naïve to potent opioids
Low-dose overlap initiation with split tablets of buprenorphine in intubated intensive care unit patients with opioid use disorder
Low dose oral and transdermal therapy of hypertension
Low-dose lithium against dementia
Pain Control in Latin America: The Optimized Role of Buprenorphine in the Treatment of Cancer and Noncancer Pain
Single high-dose buprenorphine for opioid craving during withdrawal
“I don’t want to take buprenorphine for the rest of my life”: Acceptance and Commitment Therapy for a Client Struggling to Reduce Low-Dose Buprenorphine (a Hermeneutic Single-Case Efficacy Design)
Low-dose oral methotrexate-induced crystalluria
Buprenorphine plasma and cerebrospinal fluid concentrations in osteoarthritis patients during low-dose transdermal patch dosing
Transdermal buprenorphine in cancer pain and palliative care
Cancer and non-cancer brain and eye effects of chronic low-dose ionizing radiation exposure
Rapid induction of transdermal buprenorphine to subcutaneous extended-release buprenorphine for the treatment of opioid use disorder
A 6-months, randomised, placebo-controlled evaluation of efficacy and tolerability of a low-dose 7-day buprenorphine transdermal patch in osteoarthritis patients naïve to potent opioids
Low-dose overlap initiation with split tablets of buprenorphine in intubated intensive care unit patients with opioid use disorder
Low dose oral and transdermal therapy of hypertension
Low-dose lithium against dementia
Pain Control in Latin America: The Optimized Role of Buprenorphine in the Treatment of Cancer and Noncancer Pain
Single high-dose buprenorphine for opioid craving during withdrawal
“I don’t want to take buprenorphine for the rest of my life”: Acceptance and Commitment Therapy for a Client Struggling to Reduce Low-Dose Buprenorphine (a Hermeneutic Single-Case Efficacy Design)
Low-dose oral methotrexate-induced crystalluria
Buprenorphine plasma and cerebrospinal fluid concentrations in osteoarthritis patients during low-dose transdermal patch dosing
Transdermal buprenorphine in cancer pain and palliative care
Cancer and non-cancer brain and eye effects of chronic low-dose ionizing radiation exposure
Rapid induction of transdermal buprenorphine to subcutaneous extended-release buprenorphine for the treatment of opioid use disorder
A 6-months, randomised, placebo-controlled evaluation of efficacy and tolerability of a low-dose 7-day buprenorphine transdermal patch in osteoarthritis patients naïve to potent opioids
Low-dose overlap initiation with split tablets of buprenorphine in intubated intensive care unit patients with opioid use disorder
Low dose oral and transdermal therapy of hypertension
Low-dose lithium against dementia
Pain Control in Latin America: The Optimized Role of Buprenorphine in the Treatment of Cancer and Noncancer Pain
Single high-dose buprenorphine for opioid craving during withdrawal
“I don’t want to take buprenorphine for the rest of my life”: Acceptance and Commitment Therapy for a Client Struggling to Reduce Low-Dose Buprenorphine (a Hermeneutic Single-Case Efficacy Design)